|
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| The first 300 words of the full text of this article appear below. |
| Objectives |
|---|
| Introduction |
|---|
The pathophysiology of bronchiolitis begins with an acute infection of the epithelial cells lining the small airways within the lungs. Such infection results in edema, increased mucus production, and eventual necrosis and regeneration of these cells. The clinical presentation of bronchiolitis includes rhinitis, cough, tachypnea, use of accessory respiratory muscles, hypoxia, and variable wheezing and crackles on auscultation.
The evaluation and management of bronchiolitis varies substantially. Although bronchiolitis is a well-recognized clinical syndrome, additional tests such as viral isolation, blood serology, and chest radiographs often are ordered, although they have little impact on diagnosis. Most clinical interventions have no significant impact on length of hospital stay, severity of clinical course, or subsequent outcomes such as episodes of recurrent wheezing or ultimate diagnosis of asthma. In 2006, the American Academy of Pediatrics (AAP) released a clinical practice guideline for the diagnosis, testing, and management of bronchiolitis (Table 1). (1) These recommendations are
![]()
CiteULike
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter What's this?
Click here for Bronchiolitis CORRECTION Data Supplement
| HOME | HELP | CONTACT US | SUBSCRIPTIONS | CME | ARCHIVE | SEARCH | TABLE OF CONTENTS |